Nasdaq's Hearings Panel granted SCWorx Corp. a request to continue its common stock listing following a trading suspension on April 14, 2026, due to failure to meet the $1.00 minimum bid price requirement. To reinstate trading, the company must obtain shareholder approval for a reverse stock split by July 22, 2026, execute the split by August 3, 2026, and maintain a closing bid price of at least $1.00 for 20 consecutive trading days by August 28, 2026. Failure to meet these conditions will result in delisting from Nasdaq. SCWorx Corp. is currently quoted on the OTCQB Market. The company operates in the technology and healthcare services sector.
